Christopher M. Hillis

Hamilton, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Reframing chronic myeloid leukemia outcomes beyond survival: a perspective of quality of life and patient-centered data.

Reframing chronic myeloid leukemia outcomes beyond survival: a perspective of quality of life and patient-centered data.

Journal: Blood reviews

Published: May 19, 2026

Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).

Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).

Journal: Lancet regional health. Americas

Published: March 25, 2026

Title Not Found

Title Not Found

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: August 11, 2025

Diagnosis and management of iron deficiency in females.

Diagnosis and management of iron deficiency in females.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: July 02, 2025

Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes study.

Novel method for trend change detection and hypothesis generation in hemovigilance: A transfusion-related immunomodulation and blood production changes study.

Journal: Transfusion

Published: May 08, 2025

Efficacy and cardiovascular safety of liposomal doxorubicin: a systematic review and meta-analysis of randomized trials.

Efficacy and cardiovascular safety of liposomal doxorubicin: a systematic review and meta-analysis of randomized trials.

Journal: Cardio-oncology (London, England)

Published: March 28, 2025

A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.

A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.

Journal: Frontiers in medicine

Published: January 11, 2025

Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Early Cardiovascular Events in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: JACC. Advances

Published: December 23, 2024

ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera.

ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera.

Journal: Acta haematologica

Published: December 16, 2024

The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab.

The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab.

Journal: Cancers

Published: August 15, 2024

"Discrepant low von Willebrand factor activity results on the ACL TOP analyzer are frequent in unselected patients with myeloproliferative neoplasms and show no correlation with high-molecular-weight multimer loss or bleeding phenotype": comment from Al Sharif et al.

"Discrepant low von Willebrand factor activity results on the ACL TOP analyzer are frequent in unselected patients with myeloproliferative neoplasms and show no correlation with high-molecular-weight multimer loss or bleeding phenotype": comment from Al Sharif et al.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 31, 2024

How a Canadian federal organization integrated synoptic reporting and quality improvement tools to drive a national learning health system in cancer surgery.

How a Canadian federal organization integrated synoptic reporting and quality improvement tools to drive a national learning health system in cancer surgery.

Journal: Healthcare management forum

Published: March 14, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026